I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Dreyling, M.
~ 300
results:
Search for persons
X
Format
Online
Print
Mediatypes
Books
Articles (Online)
Bookchapter (Online)
OpenAccess-fulltext
Languages
german (20)
english (254)
Sorted by: Relevance
Sorted by: Year
?
1
Primary central nervous system lymphomas: EHA–ESMO Clinical..:
Ferreri, A.J.M.
;
Illerhaus, G.
;
Doorduijn, J.K.
...
Annals of Oncology. 35 (2024) 6 - p. 491-507 , 2024
Link:
https://doi.org/10.1016/..
?
2
LONG-TERM DURABLE RESPONSES IN PATIENTS (PTS) WITH RELAPSED..:
Awasthi, R.
;
Waldron, E.
;
Grupp, S.A.
...
Cytotherapy. 26 (2024) 6 - p. S152 , 2024
Link:
https://doi.org/10.1016/..
?
3
UNMET NEED IN RELAPSED/REFRACTORY (R/R) MANTLE CELL LYMPHOM..:
Dreyling, M.
;
Shah, B.
;
Wu, J.
...
Hematological Oncology. 41 (2023) S2 - p. 755-757 , 2023
Link:
https://doi.org/10.1002/..
?
4
Five‐year subgroup analysis of tafasitamab + lenalidomide f..:
Duell, J.
;
Abrisqueta, P.
;
Dreyling, M.
...
Hematological Oncology. 41 (2023) S2 - p. 439-441 , 2023
Link:
https://doi.org/10.1002/..
?
5
CONSOLIDATIVE HCT‐ASCT IS SUPERIOR TO NON‐MYELOABLATIVE CHE..:
Illerhaus, G.
;
Ferreri, A.
;
Binder, M.
...
Hematological Oncology. 41 (2023) S2 - p. 41-43 , 2023
Link:
https://doi.org/10.1002/..
?
6
CELL‐FREE DNA KINETICS DECIPHER POTENTIAL MECHANISMS OF ACT..:
Khouja, M.
;
Genuardi, E.
;
Ferrero, S.
...
Hematological Oncology. 41 (2023) S2 - p. 181-183 , 2023
Link:
https://doi.org/10.1002/..
?
7
HIGH RATE OF METABOLIC COMPLETE RESPONSE AFTER LOW DOSE RAD..:
Herfarth, K.
;
Scholz, C. W.
;
Hübel, K.
...
Hematological Oncology. 41 (2023) S2 - p. 218-220 , 2023
Link:
https://doi.org/10.1002/..
?
8
TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALE..:
Morschhauser, F.
;
Dahiya, S.
;
Palomba, M. L.
...
Hematological Oncology. 41 (2023) S2 - p. 877-880 , 2023
Link:
https://doi.org/10.1002/..
?
9
Final safety and efficacy results of copanlisib monotherapy..:
Dreyling, M.
;
Santoro, A.
;
Mollica, L.
...
Hematological Oncology. 41 (2023) S2 - p. 560-562 , 2023
Link:
https://doi.org/10.1002/..
?
10
EPH163 Burden of Diffuse Large B-Cell Lymphoma (DLBCL) in G..:
Moertl, B
;
Beier, D
;
Schmidt, C
...
Value in Health. 25 (2022) 12 - p. S222 , 2022
Link:
https://doi.org/10.1016/..
?
11
P1438: PROCALCITONIN IS ELEVATED IN SEVERE INFECTIONS AFTER..:
Rejeski, K.
;
Blumenberg, V.
;
Hildebrand, F.
...
HemaSphere. 6 (2022) - p. 1321-1322 , 2022
Link:
https://doi.org/10.1097/..
?
12
P1154: STUDY ZILO-301: A PHASE 3, RANDOMIZED, DOUBLE-BLIND,..:
Yazji, S.
;
Hamburger, S.
;
Wang, Y.
...
HemaSphere. 6 (2022) - p. 1041-1042 , 2022
Link:
https://doi.org/10.1097/..
?
13
SA29 Efficacy Outcomes Following Treatment with Bruton Tyro..:
Dreyling, M
;
Shah, B
;
Wu, JJ
...
Value in Health. 25 (2022) 7 - p. S609-S610 , 2022
Link:
https://doi.org/10.1016/..
?
14
P1100: BRUIN MCL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUD..:
Eyre, T. A.
;
Shah, N. N.
;
Le Gouill, S.
...
HemaSphere. 6 (2022) - p. 990-991 , 2022
Link:
https://doi.org/10.1097/..
?
15
Managing hematological cancer patients during the COVID-19 ..:
Buske, C.
;
Dreyling, M.
;
Alvarez-Larrán, A.
...
ESMO Open. 7 (2022) 2 - p. 100403 , 2022
Link:
https://doi.org/10.1016/..
1-15